AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
This monthly newsletter covers news on biotechnology lab, manufacturing equipment and products, and vendor research.
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Biotech Equipment Update back issues
|
|
MINIMAL INVASIVE CANCER-FIGHTING ROBOT UNVEILED.
July 1, 2009... At the recent ILSI-Biomed Israel Conference, Israel's premier life sciences event, it was announced that a miniature crawling robot (ViRob) with the potential to treat lung cancer by performing precise medical procedures inside the human body,
The ViRob can navigate and crawl in different...
PMI CLEARED TO LAUNCH INTELLIGENT SURGICAL INSTRUMENT CONSOLE.
July 1, 2009... Power Medical Interventions, Inc. (OTCBB: PMII.OB), Langhorne, Penn., a leader in developing and commercializing Intelligent Surgical Instruments, has announced that the U.S. Food and Drug Administration (FDA) has cleared its 510(k) application for marketing its iDrive Intelligent Power...
IRISH FIRM CROSPON UNVEILS ENDOFLIP GASTROENTEROLOGY.
July 1, 2009... Underscoring Ireland's emergence as an innovation leader in gastroenterology technology and treatment, a host of Irish companies from across the country and across a range of medical and pharmaceutical disciplines are traveling to Chicago, Illinois to showcase their innovations at the...
PRESSURE BIOSCIENCES TO DEBUT PCT MICROTUBE ADAPTER KIT.
July 1, 2009... Pressure BioSciences, Inc. (Nasdaq:PBIO), South Easton, Mass, will unveil and release for sale its PCT MicroTube Adapter Kit (patent pending) at the 57th Annual Conference of the American Society for Mass Spectrometry (ASMS), to be held at the Pennsylvania Convention Center (Philadelphia, PA)...
ORBUSNEICH'S GENOUS BIO-ENGINEERED STENT HAS GOOD RESULTS.(Clinical report)
June 1, 2009... At a recent symposium, Margo Klomp, MD from the Academic Medical Center (AMC), Amsterdam, The Netherlands, reported that final adjudicated 12 month follow up results from the randomized AMC single center TRIAS High Risk (HR) study showed a slightly higher target lesion revascularization (TLR)...